We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.09%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$269B
AUM Growth
+$11B
(+4.3%)
Cap. Flow
-$7.32B
Cap. Flow
% of AUM
-2.72%
Top 10 Holdings %
Top 10 Hldgs %
22.8%
Holding
3,195
New
25
Increased
1,065
Reduced
1,860
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$425M |
| 3 |
Boeing
BA
|
+$396M |
| 4 |
Linde
LIN
|
+$381M |
| 5 |
ExxonMobil
XOM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.4B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$323M |
| 3 |
Accenture
ACN
|
+$264M |
| 4 |
Microsoft
MSFT
|
+$258M |
| 5 |
Union Pacific
UNP
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 11.54% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
MetroCity Bankshares
MCBS
$1.03B
| $1.13M | ﹤0.01% |
65,985
-4,850
| -7% | -$94.6K |
|
2527
Sight Sciences
SGHT
$412M
| $1.12M | ﹤0.01% |
128,529
+25,366
| +25% | +$282K |
|
2528
Powell Industries
POWL
$7.71B
| $1.12M | ﹤0.01% |
79,098
-8,082
| -9% | -$112K |
|
2529
RxSight
RXST
$260M
| $1.12M | ﹤0.01% |
67,352
+3,474
| +5% | +$49.1K |
|
2530
C4 Therapeutics
CCCC
$412M
| $1.12M | ﹤0.01% |
356,609
-20,915
| -6% | -$123K |
|
2531
IES Holdings
IESC
$15.2B
| $1.12M | ﹤0.01% |
25,952
-2,780
| -10% | -$114K |
|
2532
Capital City Bank Group
CCBG
$890M
| $1.12M | ﹤0.01% |
38,088
-3,775
| -9% | -$123K |
|
|
IGMS
2533
DELISTED
IGM Biosciences
IGMS
| $1.11M | ﹤0.01% |
81,169
-1,935
| -2% | -$40K |
|
2534
Mitek Systems
MITK
$834M
| $1.1M | ﹤0.01% |
115,191
-1,051
| -0.9% | -$10.1K |
|
2535
Hingham Institution for Saving
HIFS
$663M
| $1.1M | ﹤0.01% |
4,723
-428
| -8% | -$117K |
|
2536
Sutro Biopharma
STRO
$421M
| $1.1M | ﹤0.01% |
23,846
+3,033
| +15% | +$192K |
|
2537
CleanSpark
CLSK
$3.16B
| $1.1M | ﹤0.01% |
395,029
+212,794
| +117% | +$584K |
|
2538
The Joint Corp
JYNT
$119M
| $1.1M | ﹤0.01% |
65,129
+10,403
| +19% | +$172K |
|
|
ACRE
2539
Ares Commercial Real Estate
ACRE
$270M
| $1.09M | ﹤0.01% |
120,301
-140,548
| -54% | -$1.54M |
|
2540
Heron Therapeutics
HRTX
$92.9M
| $1.09M | ﹤0.01% |
721,031
+436,516
| +153% | +$1.09M |
|
|
CSTR
2541
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $1.09M | ﹤0.01% |
71,814
-5,975
| -8% | -$99.8K |
|
2542
Lindblad Expeditions
LIND
$2.22B
| $1.08M | ﹤0.01% |
113,389
-63,748
| -36% | -$641K |
|
2543
Riley Exploration Permian
REPX
$758M
| $1.07M | ﹤0.01% |
28,255
-1,346
| -5% | -$43.4K |
|
|
BASE
2544
DELISTED
Couchbase
BASE
| $1.06M | ﹤0.01% |
75,604
-17,690
| -19% | -$261K |
|
2545
National Presto Industries
NPK
$989M
| $1.06M | ﹤0.01% |
14,694
-1,554
| -10% | -$113K |
|
2546
Lyell Immunopharma
LYEL
$360M
| $1.06M | ﹤0.01% |
22,380
-2,471
| -10% | -$132K |
|
|
SLGC
2547
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $1.06M | ﹤0.01% |
414,633
-39,234
| -9% | -$112K |
|
2548
Fiverr
FVRR
$339M
| $1.06M | ﹤0.01% |
30,253
-3,837
| -11% | -$140K |
|
2549
Liquidia Corp
LQDA
$8.02B
| $1.06M | ﹤0.01% |
152,808
-45,495
| -23% | -$311K |
|
2550
Omega Flex
OFLX
$312M
| $1.05M | ﹤0.01% |
9,445
-80
| -0.8% | -$8.68K |
|
Similar funds
VFT
Nuveen's Q1 2023 Portfolio in Review
As of Q1 2023, Nuveen held 3,195 positions worth $269B, up 4.3% from $258B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.3%. Nuveen opened 25 new positions and exited 81, leaving the 3,195-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q1 2023 buy was GE HealthCare: 1,240,905 shares worth $102M.
- Nuveen added most to Meta Platforms (Facebook) in Q1 2023, an estimated $1.08B increase.
- Nuveen's biggest Q1 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.4B.
- Nuveen fully exited SVB Financial Group in Q1 2023, selling an estimated $51.6M.
- Nuveen's ten largest holdings make up 23% of its $269B portfolio in Q1 2023.
- Nuveen opened 25 new positions and closed 81 in Q1 2023.
- Nuveen's portfolio value rose 4.3% quarter-over-quarter to $269B.
Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.